Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: May 3, 2016
Reporting Period: First fiscal quarter ended March 31, 2016
This filing serves as a notification that the company issued a press release announcing its first-quarter 2016 results of operations. The detailed financial data is contained in the press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the announcement of Q1 2016 results.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The company expressly disclaims any obligation to release publicly any updates or changes in expectations, events, conditions, or circumstances on which forward-looking statements are based.
- Legal Disclaimer: Information in this report is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act. It shall not be incorporated by reference into other filings.
- Website Availability: The text notes that the press release is available on the company website but reserves the right to discontinue availability at any time.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 3, 2016) for actual revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the full press release.
- Check for any specific guidance or outlook statements in the press release, noting the company's disclaimer regarding future updates.
- Confirm the status of the company's website for continued access to the press release.